Clinical characterislics in 113 Turkish vitiligo patients

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 17, Issue 3, 2008, Pages 129-132

  Arýcan, Özer ^a   Koç, Kadriye ^b   Ersoy, Lütfiye ^b  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Clinical finding; Systemic disease; Vitiligo

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; THYROID HORMONE;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ANXIETY DISORDER; ARM DISEASE; ARTICLE; ASIAN; BLOOD CELL COUNT; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; FEMALE; FOLIC ACID BLOOD LEVEL; HEAD AND NECK DISEASE; HUMAN; HUMAN CELL; LABORATORY TEST; LEG DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTPATIENT DEPARTMENT; SKIN EXAMINATION; SKIN MANIFESTATION; SYSTEMIC DISEASE; TURKEY (REPUBLIC); URINALYSIS; UROGENITAL TRACT DISEASE; VITAMIN BLOOD LEVEL; VITILIGO; AGE DISTRIBUTION; COHORT ANALYSIS; COMORBIDITY; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEX DISTRIBUTION; TURKEY; VITILIGO; YOUNG ADULT;

EID: 55049102982     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mosher DB, Fitzpatrick TB, Ortanne JB. Disorders of pigmentation, hipomelanoses and hypermelanoses, In: Freedberg IM, Eisen AZ, Fitzpatrick TB, editors. Dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. p. 936-45.
2. Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol. 1999;26:653-7.
3. 12 ve folik asit düzeyleri. Turkiye Klinikleri Dermatol. 2003;13:4-10.
4. Njoo MD, Westerhof W. Vitiligo: pathogenesis and treatment. Am J Clin Dermatol. 2001;2:167-81.
5. Hann SK, Chun WH, Park YK. Clinical characteristics of progressive vitiligo. Int J Dermatol. 1997;36;353-5.
6. Liu JB, Li M, Yang S, Gui JP, Wang HY, Du WH, Zhao XY, Ren YQ, Zhu YG, Zhang XJ. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol. 2005;30:327-31.
7. Singh M, Singh G, Kanwar AJ, Belhaj MS. Clinical pattern of vitiligo in Libya. Int J Dermatol. 1985;24:233-5.
8. Ortonne JP. Vitiligo and other disorders of hypopigmentation. In: Bolognia JB, Jorizzo JL, Rapini RP, et al., editors. Dermatology 1st ed. New York: Mosby; 2003. p. 947-73.
9. Somorin AO, Krahn PM. Vitiligo: a study of 112 cases. Ann Sandi Med. 1997;17:125-7.
10. Fried RG, Gupta MA, Gupta AK. Depression and skin disease. Dermatol Clin. 2005;23:657-64.
11. Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in psoriasis and vitiligo: a comparative study from India. J Dermatol. 2001;28:424-32.
12. Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol. 2001;28:419-23.
13. Urpe M, Pallatini S, Lotti T. Psychosomatic factors in dermatology. Dermatol Clin. 2005;23:601-8.
14. Gould IM, Gray RS, Urbaniak SJ, Elton RA, Duncan LJP. Vitiligo in diabetes mellitus. Br J Dermatol. 1985;113:153-5.
15. Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology. 1991;3:89-91.
16. Arýcan Ö, Papmaz S, Çetinkaya A. Vitiligo tip ve progresyonunda tiroid hormonlarýnýn rolü. Türkderm. 2003;37:269-73.
17. Grunnet I, Howitz J, Reymann F, Schawartz M. Vitiligo and pernicious anemia. Arch Dermatol. 1970;101:82-5.
18. Allison JR, Curtis AC. Vitiligo and pernicious anemia. Arch Dermatol. 1955;72:407-8.
19. Arýcan Ö, Azman E, Dervis E, Balaban D. Total serum IgE levels in vitiligo with special consideration of atopy. Acta Dermatovenerol Alp Panonica Adriat. 2004;13:86-90.
20. Powell FC, Dickens CH. Psoriasis and vitiligo. Acta Derm Venereol. 1983;63:246-9.